523 related articles for article (PubMed ID: 19171081)
21. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA.
Jansen van Vuren P; Potgieter AC; Paweska JT; van Dijk AA
J Virol Methods; 2007 Mar; 140(1-2):106-14. PubMed ID: 17174410
[TBL] [Abstract][Full Text] [Related]
23. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
24. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
Morrill JC; Peters CJ
J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
[TBL] [Abstract][Full Text] [Related]
25. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
26. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
[TBL] [Abstract][Full Text] [Related]
27. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
Morrill JC; Jennings GB; Caplen H; Turell MJ; Johnson AJ; Peters CJ
Am J Vet Res; 1987 Jul; 48(7):1042-7. PubMed ID: 3631685
[TBL] [Abstract][Full Text] [Related]
28. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
[TBL] [Abstract][Full Text] [Related]
29. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
30. An inactivated rift valley fever vaccine.
Barnard BJ; Botha MJ
J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of two next-generation Rift Valley fever vaccines.
Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
[TBL] [Abstract][Full Text] [Related]
32. Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever.
Hubbard KA; Baskerville A; Stephenson JR
Am J Vet Res; 1991 Jan; 52(1):50-5. PubMed ID: 2021254
[TBL] [Abstract][Full Text] [Related]
33. Virus-like particle-based countermeasures against Rift Valley fever virus.
Koukuntla R; Mandell RB; Flick R
Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
[TBL] [Abstract][Full Text] [Related]
34. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
Greer CE; Zhou F; Legg HS; Tang Z; Perri S; Sloan BA; Megede JZ; Uematsu Y; Vajdy M; Polo JM
Vaccine; 2007 Jan; 25(3):481-9. PubMed ID: 17052811
[TBL] [Abstract][Full Text] [Related]
35. Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein.
van der Wal FJ; Achterberg RP; de Boer SM; Boshra H; Brun A; Maassen CB; Kortekaas J
J Virol Methods; 2012 Aug; 183(2):99-105. PubMed ID: 22449758
[TBL] [Abstract][Full Text] [Related]
36. Rift Valley fever in Egypt 1986. Surveillance of sheep flocks grazing in the northeast Nile Delta.
Botros BA; Ksiazek TG; Morrill JC; Salib AW; Soliman AK; Scott RM; Barakat A
J Trop Med Hyg; 1988 Aug; 91(4):183-8. PubMed ID: 3404565
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
[TBL] [Abstract][Full Text] [Related]
39. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
40. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
